Reducing Episodic Cluster Headaches: Focus on Galcanezumab

The involvement of calcitonin gene-related peptide in migraine and cluster headache has led to the recent development of new therapies. Galcanezumab, a novel monoclonal antibody targeting the calcitonin gene-related peptide, is approved for the migraine prevention and has recently been tested for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellesi, Lanfranco, De Icco, Roberto, Al-Karagholi, Mohammad Al-Mahdi, Ashina, Messoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342329/
https://www.ncbi.nlm.nih.gov/pubmed/32753938
http://dx.doi.org/10.2147/JPR.S222604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342329/
https://www.ncbi.nlm.nih.gov/pubmed/32753938
http://dx.doi.org/10.2147/JPR.S222604

Ejemplares similares